Isala Klinieken Stichting — Clinical Trial Site

158 Registered trials

80 Currently recruiting

Organisation

Isala Klinieken Stichting

Location

Zwolle, Netherlands

Identifier

ORG-100021668

Address

Reggersweg 2, 7943 KC, Netherlands

Departments

#2202: oncology
#3726: Cardiology
031002: Pediatrics
2606:Cardiology
5003; Oncology
Afd. Interne geneeskunde
Afdeling Longgeneeskunde
Anesthesiology
Cardiology
Cardiology research
Clinical Pharmacy
Department of abdominal surgery
Department of Internal Medicines
Department of Pulmonology
Department of Radiothearpy
Dept of Medical Oncology
Dept of Oncology
Emergency Department
Gynecology and obstetrics
Hematolgoie
hematologie, oncologie
Hematology
IC Neonatology
Intensive Care
Internal Medicine
Internal Medicine - Nephrology
Internal Oncology
interne geneeskunde
Interne onc
Isala Oncology Center
Kindergeneeskunde
Longgeneeskunde
Longziekten
Lung department
Lung Diseases
Medical Oncology
Medische Oncologie
N/A
Neonatology
Nephrology
Neurologie
Neurology
NLD003:Polyclinic - Pulmonary Diseases
Obstetrics & Gynecology
Oncologie
Oncologisch Centrum
Oncology
Oncology center
Orthopedic surgery
Paediatric Gastroenterology
Pediatrics
Pneumology
Poli Longgeneeskunde
Poli Longziekten
Poli Longziekten V2.2
Pulmonary medicine
Pulmonary Science
Pulmonology
Radiology, Oncology
Radiotherapy
Reproductive medicine and gynecology
Research Department Cardiology
Research facultly
Research oncology centrum
Reumatologie
Sports Medicine
Stichting Isala Klinieken
Surgery
Urology
V2.2 poli longziekten
Vasculair geneeskundige
Verloskunde & Gynaecologie

Clinical trials at this site (158)

Search interface

A clinical study of belzutifan for treatment of kidney cancer (MK-6482-013) Ended

2022-502123-21-00 Advanced Renal Cell Carcinoma 4 2020-12-08
Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteremia (SAFE-trial) Ended

2024-515398-90-01 Staphylococcus aureus bacteremia 5 2020-08-17
A multicenter trial assessing the impact of lipoprotein (a) lowering with pelacarsen (TQJ230) on major cardiovascular events in patients wit… Ended

2023-508292-37-00 Cardiovascular Disease 5 2020-03-06
HOVON 156 AML: Treatment for acute myeloid leukemia (AML) or myelodysplastic syndrome with a FLT3 mutation with gilteritinib or midostaurin … Ended

2022-502478-18-00 Acute Myeloid Leukemia (AML) 4 2019-12-20
A randomized phase II multicenter study to assess the tolerability and efficacy of the addition of midostaurin to 10-day decitabine in unfit… Ended

2023-503829-18-00 Acute myeloid leukemia 4 2019-12-05
Liposomal iRInotecan, Carboplatin or oXaliplatin in the first line treatment of esophagogastric cancer: a randomized phase 2 study (LyRICX) Ended

2023-509287-26-00 previously untreated metastatic or locally advanced eso 4 2019-07-01
Image‐guided de‐escalation of neoadjuvant chemotherapy in HER2‐positive breast cancer: the TRAIN‐3 study Ended

2024-516205-23-00 Breast cancer 4 2019-04-09
Treatment for previously untreated patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) with an IDH1 or IDH2 mutatio… Ended

2022-502832-37-00 Acute myeloid leukemia 5 2019-03-01
DORA Trial: Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC) Ended

2024-513867-19-00 metastatic Castration-Resistant Prostate Cancer (mCRPC) 5 2019-01-31
HOVON 151 DLBCL: A phase II study evaluating the feasibility and clinical efficacy of atezolizumab consolidation treatment in high risk diff… Ended

2022-501076-26-00 high risk diffuse large B-cell lymphoma 4 2018-08-28
A randomized phase II study comparing atezolizumab after concurrent chemoradiotherapy with chemoradiotherapy alone in limited disease small-… Ended

2024-515755-37-00 Limited disease small-cell lung cancer 4 2018-07-31
HOVON 152 DLBCL. A phase II study evaluating the effect of DA-EPOCH-R induction followed by nivolumab consolidation in patients with newly d… Ended

2022-501038-48-00 Diffuse Large B-Cell Lymphoma 4 2018-07-26
Transplant BRaVE NHL: Phase I-II study combining Brentuximab Vedotin with second line salvage chemotherapy (R-DHAP) in CD30 positive diffuse… Ended

2023-510556-22-00 non-Hodgkin lymphoma (NHL) 4 2018-03-05
Endocrine therapy plus CDK 4/6 inhibition in first- or second-line for hormone receptor positive advanced breast cancer - the SONIA study Ended

2024-516204-42-00 Breast cancer 5 2017-11-21
STAR-TREC: Can we Save the rectum by watchful waiting or TransAnal surgery following (chemo)Radiotherapy versus Total mesorectal excision fo… Ended

2024-516106-31-00 Early stage colorectal cancer 10 2017-06-16
PALLAS - PALbociclib CoLlaborative Adjuvant Study: A randomized phase III trial of Palbociclib with standard adjuvant endocrine therapy vers… Ended

2024-514841-12-00 To determine whether the addition of palbociclib to adj 5 2015-10-27
HOVON 127 BL / SAKK 37/16: Phase III study comparing 2 treatments (R-CODOX-M/R-IVAC versus DA-EPOCH-R) in patients with Burkitt lymphoma Ended

2023-503423-25-00 Burkitt lymphoma 5 2014-06-19
PUMP-IT RCT: Hepatic arterial infusion PUMP chemotherapy combined with systemic therapy versus systemic therapy alone as Induction Therapy f… Halted

2023-506194-35-00 Colorectal liver metastases 5 2024-11-21
THE (COST)EFFECTIVENESS OF NEOADJUVANT FOLFIRINOX VERSUS NEOADJUVANT GEMCITABINE BASED CHEMORADIOTHERAPY AND ADJUVANT GEMCITABINE FOR (BORDE… Ended

2024-516260-29-00 non-metastatic (borderline) resectable pancreatic cance 5 2024-10-10
A study to learn more about how well BAY 3018250 works and how safe it is for people with proximal deep vein thrombosis Ended

2023-503315-15-00 Thrombolysis of symptomatic proximal vein thrombosis 4 2023-12-20
MERCURI-2 Ended

2024-515260-31-00 AKI 6 2023-06-09
Long-term Efficacy and Safety of Tozorakimab in Participants with Chronic Obstructive Pulmonary Disease with a History of Exacerbations. Ended

2022-501063-41-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2023-04-20
A study to test asundexian for preventing a stroke caused by a clot in participants after an acute ischemic stroke or after a high-risk tran… Ended

2023-503793-20-00 Prevention of ischemic stroke in patients post acute no 5 2023-01-18
A Study to Evaluate the Efficacy and Safety of Astegolimab in Patients With Chronic Obstructive Pulmonary Disease (COPD) Ended

2023-507093-40-00 Chronic Obstructive Pulmonary Disease (COPD) 4 2022-01-27